Back to FAIRFAX FINANCIAL HOLDINGS LTD/ CAN FAIRFAX FINANCIAL HOLDINGS LTD/ CAN

RVNCRVNC
2 quarters

Position history for FAIRFAX FINANCIAL HOLDINGS LTD/ CANFAIRFAX FINANCIAL HOLDINGS LTD/ CAN's holdings in REVANCE THERAPEUTICS INC

As of its Q4 2024 13F, Fairfax Financial Holdings held 21,158 shares of RVNC (Revance Therapeutics), worth $64,109.

Final Value

$0

Final Shares

0

Total Value Change

-$64,109

Total Shares Change

-21,158

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
New
21,158
-
$64,1090.0%—
30

Other major holders of RVNC: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used